This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Innovations of Andrew J Walsh in Sodium Chloride Aerosol Formulations
Introduction
Andrew J Walsh is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of aerosol formulations, particularly focusing on sodium chloride. His innovative work has led to the development of methods that enhance the dispersibility of sodium chloride for inhalation purposes.
Latest Patents
Andrew J Walsh holds a patent for the "Preparation of sodium chloride aerosol formulations." This patent discloses a method for preparing sodium chloride formulations that have a substantially uniform particle size. The method ensures that the particles are suitable for inhalation into the lungs of a subject. The process involves jet milling coarse sodium chloride using air pressure to produce particles with a significant fraction measuring less than about 7 microns in size. Following the milling process, the particles are vacuum dried in an oven to prevent substantial aggregation over time. This innovative approach has the potential to improve therapeutic applications in respiratory treatments.
Career Highlights
Andrew J Walsh is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Andrew Reginald Clark and Chung C Hsu. Their collaborative efforts contribute to the advancement of research and development in aerosol formulations.
Conclusion
Andrew J Walsh's contributions to the field of sodium chloride aerosol formulations demonstrate his commitment to innovation and improving healthcare solutions. His patent and work at Genentech highlight the importance of research in developing effective treatments for respiratory conditions.